Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogenei...
Main Authors: | Alexander W Kay, Catherine A Blish |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00289/full |
Similar Items
-
Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01) -
Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01) -
Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials
by: Alexander Domnich, et al.
Published: (2020-06-01) -
Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review
by: Amit Bansal, et al.
Published: (2021-10-01) -
Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program
by: Andrei Shanko, et al.
Published: (2020-12-01)